MDimune The Pioneer of Cell-Derived-Vesicle Therapeutics
Our BioDrone platform will enable highly targeted drug delivery to specific lesions or abrasions and allow for treatment with minimum side effects and maximum efficacy of the drugs eventually,” reveals Seung Wook Oh, Chief Scientific Officer at MDimune and Chief Executive Officer at Biodrone Therapeutics.The magnitude of what this means has sent shockwaves across the sector.After years of extensive research, development, blood, sweat, and toil, MDimune has created a cell-derived vesicle (CDV)-ba..
2022.05.01